Suppr超能文献

瑞芬太尼镇痛下床边二极管激光光凝治疗早产儿视网膜病变:早期结构结果

Bedside Diode Laser Photocoagulation Under Remifentanil Analgesia for Retinopathy of Prematurity: Early Structural Outcomes.

作者信息

Şekeroğlu Mehmet Ali, Hekimoğlu Emre, Özcan Beyza, Baş Ahmet Yağmur, Demirel Nihal, Karakaya Jale

机构信息

Ulucanlar Eye Training and Research Hospital, Ankara, Turkey.

Zübeyde Hanım Maternity and Research Hospital, Ophthalmology Clinic, Ankara, Turkey.

出版信息

Turk J Ophthalmol. 2016 Oct;46(5):209-214. doi: 10.4274/tjo.04557. Epub 2016 Oct 17.

Abstract

OBJECTIVES

To evaluate one-year structural outcomes of bedside diode laser photocoagulation with remifentanil analgesia for retinopathy of prematurity (ROP) and discuss clinical and demographic characteristics of infants and other possible risk factors that may affect the outcome.

MATERIALS AND METHODS

The medical records of premature infants who were treated with bedside transpupillary diode laser photocoagulation under remifentanil analgesia for ROP were evaluated for clinical and demographic characteristics, accompanying systemic risk factors, laser parameters, complications of treatment, retreatment rate and one-year structural outcomes.

RESULTS

One-hundred and ninety-five eyes of 99 infants (59 males, 40 females) were recruited for the study. The mean gestational age and birth weight were 27.4±2.3 weeks (23-34) and 1003.3±297.8 g (570-2250), respectively. Laser therapy was performed for high-risk prethreshold ROP in 66.2% of eyes, aggressive posterior ROP (APROP) in 15.4% and threshold ROP in 18.4%. The mean number of laser spots was 1510.4±842.1 per laser session. No adverse effects of laser photocoagulation were observed except small lens opacities in two eyes and corneal opacity in one eye. Retreatment was needed in only three eyes, and vitreoretinal surgery was needed in six eyes of six patients despite laser treatment. Anatomic outcome was favorable in 189 eyes (96.9%) at the end of a 1-year follow-up. Presence of dilated and tortuous iris vessels (p=0.002) and tunica vasculosa lentis (p=0.009) along with type of ROP (APROP and stage 4a ROP at initial presentation) (p=0.001) were associated with poor anatomical outcome.

CONCLUSION

Accurate and timely bedside transpupillary diode-laser photocoagulation under remifentanil analgesia is an effective and safe treatment modality for ROP, and may prevent vision-threatening retinal detachment and reduce the need for vitreoretinal surgery.

摘要

目的

评估在瑞芬太尼镇痛下进行床旁二极管激光光凝治疗早产儿视网膜病变(ROP)的一年结构转归,并探讨婴儿的临床和人口统计学特征以及其他可能影响转归的危险因素。

材料与方法

对在瑞芬太尼镇痛下接受床旁经瞳孔二极管激光光凝治疗ROP的早产儿病历进行评估,分析其临床和人口统计学特征、伴随的全身危险因素、激光参数、治疗并发症、再次治疗率和一年结构转归。

结果

本研究纳入了99例婴儿(59例男性,40例女性)的195只眼。平均胎龄和出生体重分别为27.4±2.3周(23 - 34周)和1003.3±297.8克(570 - 2250克)。66.2%的眼睛因高危阈值前期ROP接受激光治疗,15.4%因侵袭性后部ROP(APROP)接受治疗,18.4%因阈值ROP接受治疗。每次激光治疗的平均光斑数为1510.4±842.1个。除了两只眼睛出现小的晶状体混浊和一只眼睛出现角膜混浊外,未观察到激光光凝的不良反应。仅三只眼睛需要再次治疗,尽管进行了激光治疗,仍有6例患者的6只眼睛需要进行玻璃体视网膜手术。在1年随访结束时,189只眼(96.9%)的解剖学转归良好。虹膜血管扩张迂曲(p = 0.002)、晶状体血管膜(p = 0.009)以及ROP类型(初次就诊时为APROP和4a期ROP)(p = 0.001)与不良解剖学转归相关。

结论

在瑞芬太尼镇痛下准确、及时地进行床旁经瞳孔二极管激光光凝是治疗ROP的一种有效且安全的治疗方式,可预防威胁视力的视网膜脱离并减少玻璃体视网膜手术的需求。

相似文献

本文引用的文献

1
Pathophysiology and mechanisms of severe retinopathy of prematurity.早产儿严重视网膜病变的病理生理学及机制
Ophthalmology. 2015 Jan;122(1):200-10. doi: 10.1016/j.ophtha.2014.07.050. Epub 2014 Oct 14.
5
Challenges of ophthalmic care in the developing world.发展中国家眼科护理的挑战。
JAMA Ophthalmol. 2014 May;132(5):640-4. doi: 10.1001/jamaophthalmol.2014.84.
7
Screening examination of premature infants for retinopathy of prematurity.早产儿视网膜病变的筛查检查。
Pediatrics. 2013 Jan;131(1):189-95. doi: 10.1542/peds.2012-2996. Epub 2012 Dec 31.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验